Dexcom’s biggest triumph and its biggest let down this quarter both involved the FDA. On the positive side, a verdict from a special FDA panel means Dexcom may soon be able to change its CGM’s ...
SAN DIEGO-- (BUSINESS WIRE)--Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United States, today announced ...
The FDA has officially cleared the Dexcom G5 continuous glucose monitor to inform treatment decisions -- without the use of a fingerstick glucometer, other than for calibration. The G5 has been ...
On the day of the approval, top FDA and CMS officials write in JAMA of the need to share data for better healthcare delivery. The FDA today expanded its approval for Dexcom’s G5 mobile continuous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback